BR9809429A - Diazepinoindolonas inibidoras de fosfodiesterase 4 - Google Patents
Diazepinoindolonas inibidoras de fosfodiesterase 4Info
- Publication number
- BR9809429A BR9809429A BR9809429-7A BR9809429A BR9809429A BR 9809429 A BR9809429 A BR 9809429A BR 9809429 A BR9809429 A BR 9809429A BR 9809429 A BR9809429 A BR 9809429A
- Authority
- BR
- Brazil
- Prior art keywords
- formula
- compounds
- phosphodiesterase
- diazepinoindolones
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Patente de Invenção: <B>"DIAZEPINOINDOLONAS INIBIDORAS DE FOSFODIESTERASE 4"<D>. A presente invenção apresenta compostos que inibem a fosfodiesterase 4 tendo fórmula (l). A presente invenção também fornece métodos para uso dos compostos de fórmula (l) para prevenir ou tratar asma, dermatite atópica, artrite reumatóide, doenças inflamatórias do intestino, hipertensão pulmonar, lesão do fígado, perda óssea, choque séptico ou esclerose múltipla, e a composições farmacêuticas que contêm os compostos de fórmula (l).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705422A FR2762841B1 (fr) | 1997-04-30 | 1997-04-30 | Diazepino-indolones inhibitrices de phosphodiesterases iv |
PCT/EP1998/002827 WO1998049169A1 (en) | 1997-04-30 | 1998-04-30 | Phosphodiesterase 4-inhibiting diazepinoindolones |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9809429A true BR9809429A (pt) | 2000-06-13 |
Family
ID=9506517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9809429-7A BR9809429A (pt) | 1997-04-30 | 1998-04-30 | Diazepinoindolonas inibidoras de fosfodiesterase 4 |
Country Status (17)
Country | Link |
---|---|
US (1) | US6239130B1 (pt) |
EP (1) | EP0980374B1 (pt) |
JP (1) | JP2001522367A (pt) |
KR (1) | KR20010020386A (pt) |
AT (1) | ATE232534T1 (pt) |
AU (1) | AU729495B2 (pt) |
BR (1) | BR9809429A (pt) |
CA (1) | CA2278217A1 (pt) |
DE (1) | DE69811360T2 (pt) |
DK (1) | DK0980374T3 (pt) |
ES (1) | ES2190083T3 (pt) |
FR (1) | FR2762841B1 (pt) |
HR (1) | HRP980231B1 (pt) |
MX (1) | MXPA99006979A (pt) |
NZ (1) | NZ337589A (pt) |
WO (1) | WO1998049169A1 (pt) |
ZA (1) | ZA983704B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2795731B1 (fr) * | 1999-07-02 | 2001-09-07 | Warner Lambert Co | PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES |
WO2001064669A1 (en) * | 2000-03-03 | 2001-09-07 | Pfizer Products Inc. | Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
EP1161949A1 (en) | 2000-06-09 | 2001-12-12 | Warner-Lambert Company | Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
ES2427930T3 (es) | 2001-05-23 | 2013-11-04 | Mitsubishi Tanabe Pharma Corporation | Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos |
WO2002094321A1 (fr) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Compositions favorisant la guérison d'une fracture osseuse |
AU2002317377A1 (en) * | 2001-07-20 | 2003-03-03 | Cancer Research Technology Limited | Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
WO2006073413A1 (en) * | 2004-02-20 | 2006-07-13 | The Board Of Trustees Of The University Of Illinois | Blood pressure reduction in salt-sensitive |
WO2005102317A1 (en) * | 2004-04-23 | 2005-11-03 | Celgene Corporation | Methods of using and compositions comprising pde4 modulators for the treatment and management of pulmonary hypertension |
MX2007012711A (es) * | 2005-04-19 | 2008-01-11 | Nycomed Gmbh | Roflumilast para el tratamiento de hipertension pulmonar. |
WO2008041118A2 (en) * | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
CA2682730A1 (en) * | 2007-04-11 | 2008-10-23 | Alcon Research, Ltd. | Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
MX2009013990A (es) * | 2007-06-26 | 2010-03-30 | Lexicon Pharmaceuticals Inc | Metodos para tratar enfermedades y trastornos mediados por serotonina. |
BR112012007091A2 (pt) * | 2009-10-01 | 2016-04-19 | Alcon Res Ltd | composições de olopatadina e seus usos |
CN113423435A (zh) | 2018-12-28 | 2021-09-21 | 雷杰纳荣制药公司 | 使用花生四烯酸15-脂氧合酶(alox15)抑制剂治疗呼吸系统病症 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2725719B1 (fr) * | 1994-10-14 | 1996-12-06 | Jouveinal Inst Rech | Diazepino-indoles inhibiteurs de phosphodiesterases iv |
-
1997
- 1997-04-30 FR FR9705422A patent/FR2762841B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-29 HR HR980231A patent/HRP980231B1/xx not_active IP Right Cessation
- 1998-04-30 CA CA002278217A patent/CA2278217A1/en not_active Abandoned
- 1998-04-30 MX MXPA99006979A patent/MXPA99006979A/es unknown
- 1998-04-30 ZA ZA9803704A patent/ZA983704B/xx unknown
- 1998-04-30 KR KR1019997010008A patent/KR20010020386A/ko not_active Application Discontinuation
- 1998-04-30 AU AU77652/98A patent/AU729495B2/en not_active Ceased
- 1998-04-30 US US09/380,883 patent/US6239130B1/en not_active Expired - Fee Related
- 1998-04-30 DE DE69811360T patent/DE69811360T2/de not_active Expired - Fee Related
- 1998-04-30 JP JP54662498A patent/JP2001522367A/ja not_active Abandoned
- 1998-04-30 EP EP98925598A patent/EP0980374B1/en not_active Expired - Lifetime
- 1998-04-30 NZ NZ337589A patent/NZ337589A/xx unknown
- 1998-04-30 AT AT98925598T patent/ATE232534T1/de not_active IP Right Cessation
- 1998-04-30 DK DK98925598T patent/DK0980374T3/da active
- 1998-04-30 WO PCT/EP1998/002827 patent/WO1998049169A1/en not_active Application Discontinuation
- 1998-04-30 BR BR9809429-7A patent/BR9809429A/pt not_active IP Right Cessation
- 1998-04-30 ES ES98925598T patent/ES2190083T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2762841B1 (fr) | 1999-07-02 |
US6239130B1 (en) | 2001-05-29 |
NZ337589A (en) | 2000-10-27 |
HRP980231B1 (en) | 2002-06-30 |
FR2762841A1 (fr) | 1998-11-06 |
AU7765298A (en) | 1998-11-24 |
EP0980374A1 (en) | 2000-02-23 |
CA2278217A1 (en) | 1998-11-05 |
AU729495B2 (en) | 2001-02-01 |
DE69811360D1 (de) | 2003-03-20 |
EP0980374B1 (en) | 2003-02-12 |
ZA983704B (en) | 1999-10-25 |
ATE232534T1 (de) | 2003-02-15 |
KR20010020386A (ko) | 2001-03-15 |
DE69811360T2 (de) | 2003-10-09 |
ES2190083T3 (es) | 2003-07-16 |
DK0980374T3 (da) | 2003-05-05 |
MXPA99006979A (es) | 2005-04-19 |
JP2001522367A (ja) | 2001-11-13 |
HRP980231A2 (en) | 2000-04-30 |
WO1998049169A1 (en) | 1998-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809429A (pt) | Diazepinoindolonas inibidoras de fosfodiesterase 4 | |
FI945557A (fi) | Isoksatsoliiniyhdisteet tulehduksenvastaisina aineina | |
ATE187447T1 (de) | 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel | |
MX9606546A (es) | Compuestos inhibidores de la enzima conversiva de interleukina-1 beta. | |
WO1997022619A3 (en) | INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | |
ATE450515T1 (de) | Anilinopyrimidinderivate als ikk?inhibitoren, und hiermit in zusammenhang stehende zusammensetzungen und verfahren | |
PL337758A1 (en) | Derivatives of piperazine and their application as anti-inflammatory agents | |
DE69824037D1 (de) | Beta-alanin-derivate als zell-adhäsions-inhibitoren | |
ES2195419T3 (es) | Inhibidores bencenosulfonamida de pde-iv y su uso terapeutico. | |
AP2000001992A0 (en) | Succinamide inhibitors of inteleukin-1B converting enzyme. | |
EA200000741A1 (ru) | Новые производные дигидроксигексановой кислоты | |
BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
PT1294729E (pt) | 2-aminoalquil-tieno[2,3-d]pirimidinas | |
MX9805015A (es) | INHIBIDORES DE LA ENZIMA QUE CONVIERTE LA INTERLEUCINA-1 beta. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007. |